It has been shown that PSMA PET has a high specificity and positive predictive value in the detection of prostate cancer lesions in patients referred for the detection of intraprostatic prostate cancer, initial staging of high-risk prostate cancer, and for staging in biochemical recurrence [5–7]. This evidence concerns the gene FOLH1 and prostate cancer.